Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Total 13F shares
-
213,137,480
-
Share change
-
+7,356,022
-
Total reported value
-
$969,776,344
-
Put/Call ratio
-
36%
-
Price per share
-
$4.55
-
Number of holders
-
223
-
Value change
-
+$6,686,675
-
Number of buys
-
144
-
Number of sells
-
80
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q3 2023
As of 30 Sep 2023,
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) was held by
223 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
213,137,480 shares.
The largest 10 holders included
VANGUARD GROUP INC, MHR FUND MANAGEMENT LLC, BlackRock Inc., STATE STREET CORP, PERCEPTIVE ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, Pictet Asset Management Holding SA, Avoro Capital Advisors LLC, Artisan Partners Limited Partnership, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
223
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.